CASI Pharmaceuticals, Inc.

CASI · NASDAQ
Analyze with AI
Filings25
Total reported value$2.3M
ManagerSharesValue
Change
VR Adviser, LLC987.3K$868.8K0.0%
Foresite Capital Management VI LLC980K$862.4K+16.4%
BANK OF AMERICA CORP /DE/254.9K$224.3K+48.8%
Woodline Partners LP165.6K$145.8K0.0%
Wellington Shields Capital Management, LLC69.5K$61.2K-44.2%
RENAISSANCE TECHNOLOGIES LLC43.9K$38.6K+9.7%
TWO SIGMA INVESTMENTS, LP33.3K$29.3K+50.0%
Wellington Shields & Co., LLC30.1K$26.5K0.0%
GEODE CAPITAL MANAGEMENT, LLC18.8K$16.6K0.0%
Ground Swell Capital, LLC10.1K$8.9K+50.0%
ROYAL BANK OF CANADA10K$8.8K0.0%
GROUP ONE TRADING, L.P.2.3K$2.0K+50.0%
WELLS FARGO & COMPANY/MN505$444.40.0%
MORGAN STANLEY365$321.20.0%
BlackRock, Inc.296$260.50.0%
BNP PARIBAS ARBITRAGE, SNC134$117.90.0%
JPMORGAN CHASE & CO25$22.00.0%
UBS Group AG14$12.3+101.5%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO13$11.40.0%
Colonial Trust Co / SC11$9.70.0%
MAI Capital Management5$4.40.0%
CITIGROUP INC0$0.0+100.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0$0.0+100.0%
TWO SIGMA SECURITIES, LLC0$0.0+100.0%
ADAR1 Capital Management, LLC0$0.0+100.0%